Jaguar Health declares Series R preferred dividend, amends royalty and note obligations

Jaguar Health, Inc.

Board declared special one-time dividend of one Series R Convertible Preferred share per common share; record date Oct 13, 2026, payment date Oct 15, 2026.
Series R designates 2,325,000 preferred shares; each converts into 5 common shares on Nov 2, 2026, up to 11,625,000 conversion shares.
Example: 2,281,247 Series R shares would yield 11,406,235 common shares, about 83.3% of outstanding common stock after conversion.
Uptown and Streeterville royalty amendments extend monthly payments from Oct 1, 2026 to Jan 1, 2027; monthly Royalty Payment is greater of $750,000 or actual amount.
2021 Note maturity extended from Oct 1, 2026 to Jan 1, 2027; C/M Capital consented to dividend and Series R authorization.

item 1.01 item 2.03 item 3.03 item 8.01 item 5.03 item 7.01 item 9.01

This headline and bullets were generated automatically by deepseek-v4.1-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.